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Not Your Typical Case Of Ascites: Pancreatic Ascites In
A Patient With Cirrhosis And Pancreatic Duct Leak
Philip Montemuro, MD and Abhik Roy, MD

Case
A 55-year-old male with a history of hepatic cirrhosis secondary
to Hepatitis C and alcohol abuse presented to an outside
hospital with progressive abdominal pain and distension. The
patient initially complained of “punching” right upper quadrant
and epigastric abdominal pain that was 10/10 in intensity and
non-radiating. Although the pain had started one to two days
prior to presentation, the patient had been experiencing several
weeks of increasing abdominal distension. He reported drinking
eight 40oz beers daily for over 40 years, and he felt that the
abdominal pain improved slightly with cessation of alcohol use.
The patient complained of nausea and non-bloody, non-bilious
vomiting, progressive dyspnea on exertion, and worsening
lower extremity edema. He denied fevers or chills.
Limited outside hospital records indicated that the patient had
been stable on diuretics for one month prior to admission. He
required three large volume paracenteses during his six days at
the outside facility, and he was transferred to Thomas Jefferson
University Hospital for further management of his refractory
ascites. Medications on transfer included lactulose, furosemide,
spironolactone, and octreotide. The patient was also receiving
total parenteral nutrition (TPN) via a Peripherally Inserted
Central Catheter (PICC).

Figure 1. Pancreatic duct leak with contrast extravasation into
the retroperitoneum (white arrow)

At the time of transfer, the patient was afebrile with stable vital
signs. On physical exam, he appeared cachectic with temporal
wasting. The abdominal exam revealed a soft abdomen with
moderate distension, diffuse tenderness to palpation without
rebound or guarding, positive fluid wave and shifting dullness,
and no organomegaly or collateral circulation. Spider angiomata
were present on the chest. Lower extremity edema, palmar
erythema, jaundice, and gynecomastia were not appreciable.
Complete blood count on transfer showed white count 10,900/L,
hemoglobin 9.1 g/dL, and platelets 110/L. The chemistry 7 was
remarkable for sodium 133 mmol/L and creatinine 0.7 mg/dL.
INR was 1.4, and liver function tests showed total protein 5.0 g/
dL, albumin 1.9 g/dL, total bilirubin 0.7 mg/dL, direct bilirubin
0.3 mg/dL, AST and ALT of 17 IU/L, and alkaline phosphatase
38 IU/L. Serum lipase and amylase were 645 U/L and 330
U/L respectively. Hepatitis C antibody was positive with a
quantitative polymerase chain reaction (PCR) of 5130 IU/mL.
On the day of transfer, a bedside paracentesis had been performed
at the outside hospital and showed clear yellow fluid with 94 red
blood cells, 69 white blood cells (15% PMN, 50% lymphocytes,
and 35% monocytes), and a negative gram stain and culture.
Ascites albumin was 0.7 g/dL, yielding a serum-ascites albumin
gradient (SAAG) of 1.2. Of note, the ascites total protein was
2.1 and ascites amylase was significantly elevated at 4000. An
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Figure 2. Two stents were placed to fix the pancreatic duct
leak and impaired biliary drainage (the white arrow shows
the pancreatic duct stent; the red arrow shows the biliary
duct stent)
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Table 1
SAAG ≥ 1.1,
Ascites protein < 2.5 g/dL

SAAG ≥ 1.1,
Ascites protein ≥ 2.5 g/dL

SAAG < 1.1

Cirrhosis

Congestive heart failure
Constrictive pericarditis

Biliary leak
Nephrotic syndrome

Late Budd-Chiari syndrome

Early Budd-Chiari syndrome
IVC obstruction

Pancreatitis
Peritoneal carcinomatosis

Massive liver metastasis

Sinusoidal obstruction syndrome

Tuberculosis

abdominal magnetic resonance imaging (MRI)/magnetic
resonance cholangiopancreatography (MRCP) had also been
performed prior to transfer, and this study demonstrated
a cirrhotic appearing liver, moderate to severe ascites with
loculated appearance, and mild stenosis of the common hepatic
duct with no intra- or extra-hepatic biliary ductal dilation or
stones and no evidence of pancreatic pseudocyst.
Given the rapid re-accumulation of ascites requiring multiple
paracenteses at the outside hospital, the differential diagnosis
at the time of transfer to Jefferson included progression of
cirrhosis due to alcohol abuse or Hepatitis C, pancreatic ascites,
hepatocellular carcinoma or metastatic liver disease, peritoneal
carcinomatosis, Budd-Chiari syndrome, and auto-immune
pancreatitis. Shortly after transfer, an abdominal Doppler
ultrasound ruled out Budd-Chiari syndrome and detailed
serum and ascitic fluid analysis (including cytology) led to the
conclusion that most malignant and auto-immune etiologies
were less likely. Given the SAAG ≥1.1 and high ascites amylase
level, progressive cirrhosis (secondary to alcohol abuse and
Hepatitis C) as well as a pancreatic etiology for ascites were
believed to play a key role.
An endoscopic retrograde cholangiopancreatography (ERCP)
was performed to evaluate the pancreas and pancreatic duct
architecture. ERCP revealed a large area of disruption of the major
pancreatic duct (MPD) in the mid-body of the pancreas with
extravasation of contrast into the retroperitoneum (Figure 1),
white arrow illustrates contrast extravasation). This finding could
certainly have explained the high amylase content in the ascitic
fluid. In order to repair the pancreatic duct leak, a 5 French 12 cm
Geenen stent was placed in the MPD across the area of mid-body
pancreatic duct disruption (Figure 2, white arrow). Of note, a
10 French 5 cm plastic stent was also placed in the biliary duct
because there appeared to be impaired drainage of contrast from
the biliary tree (Figure 2, red arrow).
Following the ERCP, the patient unfortunately developed
chemical peritonitis (secondary to contrast injection during
the ERCP procedure), which required prolonged antibiotic
therapy. The patient was placed on a low sodium diet as well as
a stable oral diuretic regimen. The combination of endoscopic,
pharmacologic, and dietary interventions ultimately decreased
the rate of re-accumulation of ascites. A repeat paracentesis
performed prior to discharge showed a dramatic decrease in the
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ascites amylase level, demonstrating resolution of the pancreatic
duct leakage which had contributed to the patient’s ascites.

Discussion
In a patient with ascites of unclear etiology, several key points
must be remembered. The most common causes of ascites are
cirrhosis (81%), malignancy (10%), and heart failure (3%).4 The
work-up should include history and physical exam, ultrasound,
and paracentesis.5
On physical exam, the most useful findings to suggest ascites
include positive fluid wave and shifting dullness, while the
absence of bulging flanks, flank dullness, or shifting dullness are
the strongest findings arguing against ascites.3 Paracentesis and
ascitic fluid analysis are essential for establishing a diagnosis
and to rule out an infection. Routine ascitic fluid studies should
include gross appearance of the fluid, total protein, albumin, cell
count and differential, as well as gram stain and culture.1,4 Other
tests to consider include fluid amylase, cytology, and many other
less common studies that can be used when clinically indicated.1
Calculating the serum-ascites albumin gradient (SAAG score) is
key for establishing a diagnosis (see Table 1).1,4,5
Pancreatic ascites causes approximately 1% of all cases
of ascites. 4 The etiology is due to disruption of the main
pancreatic duct causing pancreatic fluid accumulation in the
peritoneal cavity.2 It is most commonly associated with chronic
pancreatitis secondary to alcoholism, although 67% of patients
have no recent pancreatitis flare.6,7 It can also be caused by
an internal fistula between the pancreatic duct and peritoneal
cavity, a leaking pseudocyst, or a ruptured duct.2 Pancreatic
ascites is seen in 4% of chronic pancreatitis cases and 6-14% of
pseudocyst cases.8,9 Clinically, it can present in patients with a
history of chronic pancreatitis, recent acute pancreatitis, or new
onset ascites.
The diagnosis of pancreatic ascites is made by an elevated serum
amylase along with ascitic fluid amylase > 1000 IU/L, SAAG
<1.1, and total protein >3.1,2 In our patient, the SAAG and total
protein were not consistent with a purely pancreatic cause given
the known cirrhosis that was also contributing to his ascites.
Imaging that can be utilized for diagnostic purposes include
computed tomography (CT) scan to evaluate for a pseudocyst
or evidence of pancreatitis as well as MRCP or ERCP. MRCP is
utilized if the patient is not an ERCP candidate to examine the
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main pancreatic duct. ERCP is favored as it is both diagnostic
and therapeutic.2,10 As was the case for our patient, ERCP can
show passage of contrast from either the MPD or pseudocyst
into the peritoneal cavity. If this finding is present, a stent can be
placed to occlude the site of disruption. Treatment includes both
temporary and permanent options.2 The temporary measures
are targeted at reducing pancreatic activity. This involves
avoiding enteral feedings and utilizing naso-gastric suctioning
and TPN when indicated. Octreotide is also effective in reducing
pancreatic secretions. Permanent measures include ERCP with
stent placement or surgical interventions if this fails.2
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